辅助化疗与乳腺癌大分割全乳放疗：是时候重新思考治疗顺序了吗？ - Suppr

Adjuvant chemotherapy and hypofractionated whole breast cancer radiotherapy: Is it time to rethink the sequencing?

作者信息

Lazzari Grazia, Rago Luciana, Solazzo Angela P, Benevento Ilaria, Montagna Antonietta, Castaldo Giovanni, Silvano Giovanni

机构信息

Radiation Oncology Unit, IRCCS -CROB, 85028 Rionero in Vulture, Potenza, Italy.

出版信息

Radiother Oncol. 2022 Dec;177:247-248. doi: 10.1016/j.radonc.2022.10.012. Epub 2022 Oct 18.

DOI:10.1016/j.radonc.2022.10.012

PMID:36265682

Abstract

摘要

相似文献

Adjuvant chemotherapy and hypofractionated whole breast cancer radiotherapy: Is it time to rethink the sequencing?辅助化疗与乳腺癌大分割全乳放疗：是时候重新思考治疗顺序了吗？

Radiother Oncol. 2022 Dec;177:247-248. doi: 10.1016/j.radonc.2022.10.012. Epub 2022 Oct 18.

[Moderate hypofractionated adjuvant radiotherapy with simultaneous integrated boost for breast cancer].[乳腺癌同步整合加量的中度低分割辅助放疗]

Strahlenther Onkol. 2023 Nov;199(11):1033-1035. doi: 10.1007/s00066-023-02144-z. Epub 2023 Sep 12.

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.保乳手术后辅助适形调强放疗：一项前瞻性试验结果。

Strahlenther Onkol. 2021 Jan;197(1):48-55. doi: 10.1007/s00066-020-01689-7. Epub 2020 Oct 1.

Utilization of Hypofractionated Radiation Therapy for Breast Cancer: Perspectives From the Philippines.乳腺癌大分割放射治疗的应用：来自菲律宾的观点

Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):925-927. doi: 10.1016/j.ijrobp.2022.04.038.

Comment to "Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost".对“容积调强弧形放疗联合同步整合加量用于早期乳腺癌的大分割辅助放疗的II期试验的长期结果”的评论

Radiother Oncol. 2022 Jan;166:100. doi: 10.1016/j.radonc.2021.10.024. Epub 2021 Nov 29.

Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.未筛查的非白种人群中乳腺癌中度分割辅助放疗（START B型）方案的治疗结果

Clin Oncol (R Coll Radiol). 2016 Oct;28(10):e165-72. doi: 10.1016/j.clon.2016.05.008. Epub 2016 Jun 28.

Hypofractionated whole breast irradiation after IORT treatment is safe in patients receiving adjuvant chemotherapy.保乳术后局部短程放疗联合辅助化疗治疗安全可行。

Clin Transl Oncol. 2021 Dec;23(12):2579-2583. doi: 10.1007/s12094-021-02648-z. Epub 2021 Jun 5.

The Evolving Role of Whole Breast Hypofractionation in Older Patients With Early Breast Cancer.全乳大分割放疗在老年早期乳腺癌患者中不断演变的作用

Semin Radiat Oncol. 2022 Apr;32(2):155-158. doi: 10.1016/j.semradonc.2021.11.006.

Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.应用分光光度法评估常规分割与Hypofractionated 全乳放疗中急性放射性皮肤损伤：一项客观的随机多中心研究

Radiother Oncol. 2020 May;146:172-179. doi: 10.1016/j.radonc.2020.02.018. Epub 2020 Mar 12.

Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.美国保乳手术后采用低分割与常规全乳照射的摄取率和成本：2008-2013 年。

JAMA. 2014 Dec 17;312(23):2542-50. doi: 10.1001/jama.2014.16616.

引用本文的文献

Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review of the Adjuvant Combinations Journey.乳腺癌辅助放疗与化疗的顺序安排：序贯、同步，还是其他方式？辅助联合治疗历程的全面综述

J Clin Med. 2024 Oct 19;13(20):6251. doi: 10.3390/jcm13206251.

Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report.乳腺癌新辅助化疗后的辅助放疗：是否有显著益处？初步报告。

Breast Cancer (Dove Med Press). 2024 Jul 15;16:359-367. doi: 10.2147/BCTT.S471345. eCollection 2024.

Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance.耐辐射和耐化疗癌细胞条件培养基的组成揭示了与耐药性发展相关的 miRNA 和其他分泌因子。

Int J Mol Sci. 2023 Nov 19;24(22):16498. doi: 10.3390/ijms242216498.

Case Report: Intraoperative radiotherapy as the new standard of care for breast cancer patients with disabling health conditions or impairments.病例报告：术中放疗作为患有致残性健康状况或损伤的乳腺癌患者的新护理标准。

Front Oncol. 2023 May 18;13:1156619. doi: 10.3389/fonc.2023.1156619. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Adjuvant chemotherapy and hypofractionated whole breast cancer radiotherapy: Is it time to rethink the sequencing?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献